10FoldMed
10FoldMed22About
What does 10FoldMed do?
10FoldMed is an early-stage startup based in Israel with the vision to treat obesity and metabolic diseases. Their proprietary 10Fold™ technology aims to reverse insulin resistance through non-invasive destruction of visceral fat cells.
What is 10FoldMed's revenue?
StartupHub estimates 10FoldMed's annual revenue at $1.4B (range $1.3B to $3.3B, 65% confidence), based on comparable companies in the sector.
Where is 10FoldMed headquartered?
10FoldMed is headquartered in Tel Aviv, Israel.
When was 10FoldMed founded?
10FoldMed was founded in 2020.
What industry does 10FoldMed operate in?
10FoldMed operates in Healthcare, Obesity, MedTech, HealthTech, Biotech, Longevity.
How many employees does 10FoldMed have?
10FoldMed has approximately 7,572 people on record.
An AI copilot for doctors that provides immediate, evidence-based answers to clinical questions from peer-reviewed medical sources.
Aetios AI builds advanced clinical tools for mental health professionals, leveraging AI for psychological formulation and treatment planning.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 4 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.